相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
MicroRNA-193a and taxol combination: A new strategy for treatment of colorectal cancer
Maryam Hejazi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
APC controls Wnt-induced beta-catenin destruction complex recruitment in human colonocytes
Taybor W. Parker et al.
SCIENTIFIC REPORTS (2020)
Exosomes as potential sources of biomarkers in colorectal cancer
Yongwei Xiao et al.
CANCER LETTERS (2020)
A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies
Alexis Forterre et al.
CANCERS (2020)
The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis
Zhihua Zuo et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Serum overexpression of miR-301a and miR-23a in patients with colorectal cancer
Nasibeh Karimi et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2019)
被撤回的出版物: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer (Retracted article. See vol. 21, 2022)
Tong Liu et al.
MOLECULAR CANCER (2019)
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial
Gayathri Anandappa et al.
CLINICAL CANCER RESEARCH (2019)
miRNA-143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro
Leila Karimi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Association of microRNA-21 with efficacy of cetuximab in RAS wild-type patients in the FIRE-3 study (AIO KRK-0306) and microRNA-21's influence on gene expression in the EGFR signaling pathway.
Lisa Miller-Phillips et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Functional Effects of let-7g Expression in Colon Cancer Metastasis
Che-Mai Chang et al.
CANCERS (2019)
Circulating MicroRNAs in Cancer: Potential and Challenge
Mengying Cui et al.
FRONTIERS IN GENETICS (2019)
Integrated Analysis of miRNA and mRNA Endorses a Twenty miRNAs Signature for Colorectal Carcinoma
Andrea Angius et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Comprehensive Analysis of Human microRNA-mRNA Interactome
Olga Plotnikova et al.
FRONTIERS IN GENETICS (2019)
Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid
Jack T. Wiedrick et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Signaling pathways involved in colorectal cancer progression
Zahra Koveitypour et al.
CELL AND BIOSCIENCE (2019)
miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44
Lina Sun et al.
THERANOSTICS (2019)
Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer
Pierre Laurent-Puig et al.
CLINICAL CANCER RESEARCH (2019)
Mutant p53 in colon cancer
Mizuho Nakayama et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges
Shan-shan Zhou et al.
ACTA PHARMACOLOGICA SINICA (2018)
Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development
Luca Falzone et al.
AGING-US (2018)
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer
Paola Ulivi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Introduction of hsa-miR-103a and hsa-miR-1827 and hsa-miR-137 as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma
Ali Fasihi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS-Mutant Colon Cancer Cells
Akira Inoue et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Anti-miRNA oligonucleotides: A comprehensive guide for design
Joana Filipa Lima et al.
RNA BIOLOGY (2018)
Drug resistance and new therapies in colorectal cancer
Kevin Van der Jeught et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Combination therapy to checkmate Glioblastoma: clinical challenges and advances
Debarati Ghosh et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
miR-106a suppresses tumor cells death in colorectal cancer through targeting ATG7
Haibin Hao et al.
MEDICAL MOLECULAR MORPHOLOGY (2017)
MicroRNA-6826 and-6875 in plasma are valuable non-invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer
Taiki Kijima et al.
ONCOLOGY REPORTS (2017)
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Nico van Zandwijk et al.
LANCET ONCOLOGY (2017)
The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab
Ondrej Fiala et al.
TUMOR BIOLOGY (2017)
Overexpression of miR-10b in colorectal cancer patients: Correlation with TWIST-1 and E-cadherin expression
Rania Abdelmaksoud-Dammak et al.
TUMOR BIOLOGY (2017)
Colorectal cancer population screening programs worldwide in 2016: An update
Mercedes Navarro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
I. Kiss et al.
ONCOLOGY LETTERS (2017)
MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling
Xuemei Zhang et al.
ONCOLOGY LETTERS (2017)
E-cadherin: A potential biomarker of colorectal cancer prognosis (Review)
Niki Christou et al.
ONCOLOGY LETTERS (2017)
Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells
Ning Wu et al.
Oncotarget (2017)
The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis
Qiliang Peng et al.
ONCOTARGET (2017)
Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer
Shushan Yan et al.
ONCOTARGET (2017)
miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway
Li Jia et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
miR-125b-1 and miR-378a are predictive biomarkers for the efficacy of vaccine treatment against colorectal cancer
Hironori Tanaka et al.
CANCER SCIENCE (2017)
Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients
Igor Kiss et al.
ANTICANCER RESEARCH (2016)
MicroRNA-17∼92 inhibits colorectal cancer progression by targeting angiogenesis
Huabin Ma et al.
CANCER LETTERS (2016)
Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosis
Martha L. Slattery et al.
MODERN PATHOLOGY (2016)
A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype
E. Fessler et al.
ONCOGENE (2016)
miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer
Nan Zhang et al.
ONCOLOGY LETTERS (2016)
MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42
Yong-Xia Wang et al.
ONCOTARGET (2016)
Therapeutics in Cancer - An Emerging Concept
Maitri Y. Shah et al.
EBIOMEDICINE (2016)
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Yunching Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon
Joel Pekow et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial
F. Sclafani et al.
ANNALS OF ONCOLOGY (2015)
Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
T. F. Hansen et al.
BRITISH JOURNAL OF CANCER (2015)
Emerging role of microRNA-21 in colorectal cancer
Jun Zhao et al.
CANCER BIOMARKERS (2015)
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab
Jitka Mlcochova et al.
ONCOTARGET (2015)
Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer
Masayuki Hiraki et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro
Jun Deng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients
Mulong Du et al.
CARCINOGENESIS (2014)
MiR-135b is a direct PAX6 target and specifies human neuroectoderm by inhibiting TGF-β/BMP signaling
Akshay Bhinge et al.
EMBO JOURNAL (2014)
miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor
Martin Pichler et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1
Dengbo Ji et al.
MOLECULAR CANCER (2014)
Elevated level of microRNA-21 in the serum of patients with colorectal cancer
Gholam Basati et al.
MEDICAL ONCOLOGY (2014)
Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer
Peng Chen et al.
MEDICAL ONCOLOGY (2014)
Circulating Exosomal microRNAs as Biomarkers of Colon Cancer
Hiroko Ogata-Kawata et al.
PLOS ONE (2014)
Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection
Jia Wang et al.
PLOS ONE (2014)
miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3rd Line Cetuximab and Irinotecan
Jakob V. Schou et al.
PLOS ONE (2014)
Tissue MicroRNAs as Predictors of Outcome in Patients with Metastatic Colorectal Cancer Treated with First Line Capecitabine and Oxaliplatin with or without Bevacizumab
Mogens K. Boisen et al.
PLOS ONE (2014)
Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer
Peng Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
MicroRNA-638 inhibits cell proliferation, invasion and regulates cell cycle by targeting tetraspanin 1 in human colorectal carcinoma
Jiwei Zhang et al.
ONCOTARGET (2014)
MicroRNAs in Autoimmune Diseases
Zigang Qu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial
T. F. Hansen et al.
BRITISH JOURNAL OF CANCER (2013)
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease
E. Mogilyansky et al.
CELL DEATH AND DIFFERENTIATION (2013)
Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations
Xinmei Wang et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Identification and Validation of Reference Genes for qPCR Detection of Serum microRNAs in Colorectal Adenocarcinoma Patients
Guixi Zheng et al.
PLOS ONE (2013)
Epigenetics of Colorectal Cancer
Ajay Goel et al.
GASTROENTEROLOGY (2012)
Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps
Chung Wah Wu et al.
GUT (2012)
Discovering the first microRNA-targeted drug
Morten Lindow et al.
JOURNAL OF CELL BIOLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
The proto-oncogene Pim-1 is a target of miR-33a
M. Thomas et al.
ONCOGENE (2012)
High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease
Annamaria Ruzzo et al.
ONCOLOGIST (2012)
MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF
Neda Mosakhani et al.
CANCER GENETICS (2012)
MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
Ahmed Fawzy Ibrahim et al.
CANCER RESEARCH (2011)
Increased Expression of MicroRNA-21 and Its Association with Chemotherapeutic Response in Human Colorectal Cancer
K. Liu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
Microvesicle-mediated RNA Molecule Delivery System Using Monocytes/Macrophages
Yukihiro Akao et al.
MOLECULAR THERAPY (2011)
Structural basis of microRNA length variety
Julia Starega-Roslan et al.
NUCLEIC ACIDS RESEARCH (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Alterations of MicroRNAs Contribute to Colon Carcinogenesis
Aaron J. Schetter et al.
SEMINARS IN ONCOLOGY (2011)
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism
Sripathi M. Sureban et al.
JOURNAL OF NANOBIOTECHNOLOGY (2011)
Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening
Alexander Link et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Role of anti-oncomirs miR-143 and-145 in human colorectal tumors
Y. Akao et al.
CANCER GENE THERAPY (2010)
MiR423-5p As a Circulating Biomarker for Heart Failure
Anke J. Tijsen et al.
CIRCULATION RESEARCH (2010)
The Chromosomal Instability Pathway in Colon Cancer
Maria S. Pino et al.
GASTROENTEROLOGY (2010)
Association of MicroRNA Expression with Microsatellite Instability Status in Colorectal Adenocarcinoma
Jonathan S. L. Earle et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman et al.
GENOME RESEARCH (2009)
Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer
Remco Nagel et al.
CANCER RESEARCH (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice
Neri Mercatelli et al.
PLOS ONE (2008)
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver
Joacim Elmen et al.
NUCLEIC ACIDS RESEARCH (2008)
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
Hiroshi Tazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Tsung-Cheng Chang et al.
MOLECULAR CELL (2007)
The colorectal microRNAome
JM Cummins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Improved targeting of miRNA with antisense oligonucleotides
Scott Davis et al.
NUCLEIC ACIDS RESEARCH (2006)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation
TA Rand et al.
CELL (2005)
Nuclear export of microRNA precursors
E Lund et al.
SCIENCE (2004)
The nuclear RNase III Drosha initiates microRNA processing
Y Lee et al.
NATURE (2003)
Role for a bidentate ribonuclease in the initiation step of RNA interference
E Bernstein et al.
NATURE (2001)